Derma AI: A NON-INTERVENTIONAL, PROSPECTIVE, MULTICENTER STUDY IN JAPAN FOR DEVELOPMENT AND UTILITY INVESTIGATION OF EDUCATIONAL ARTIFICAL INTELLIGENCE (AI) SOFTWARE TO SUPPORT ASSESSMENT OF ATOPIC DERMATITIS SEVERITY
Not Applicable
- Conditions
- Atopic dermatitis (AD)
- Registration Number
- JPRN-UMIN000052645
- Lead Sponsor
- Pfizer Japan Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
Not provided
Exclusion Criteria
Participants are excluded from the study if any of the following criteria apply: 1. Patients concomitant with skin diseases which affect the area where AD skin image is photographed. 2. Patients whose symptoms are clearly in remission in the area affected by AD and whose EASI score is clearly zero. 3. Investigator site staff directly involved in the conduct of the study and their family members, site staff otherwise supervised by the investigator, and sponsor and sponsor delegate employees directly involved in the conduct of the study and their family members.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method